Population Pharmacokinetics of Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin’s Lymphoma and Exposure–Response in CLL
CPT: Pharmacometrics and Systems Pharmacology - United States
doi 10.1038/psp.2014.42
Full Text
Open PDFAbstract
Available in full text
Date
October 29, 2014
Authors
Publisher
Wiley